These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27068437)

  • 1. Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy.
    Ruan J; Martin P
    Curr Hematol Malig Rep; 2016 Jun; 11(3):234-40. PubMed ID: 27068437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study.
    Nordström L; Sernbo S; Eden P; Grønbaek K; Kolstad A; Räty R; Karjalainen ML; Geisler C; Ralfkiaer E; Sundström C; Laurell A; Delabie J; Ehinger M; Jerkeman M; Ek S
    Br J Haematol; 2014 Jul; 166(1):98-108. PubMed ID: 24684350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11.
    Croci GA; Hoster E; Beà S; Clot G; Enjuanes A; Scott DW; Cabeçadas J; Veloza L; Campo E; Clasen-Linde E; Goswami RS; Helgeland L; Pileri S; Rymkiewicz G; Reinke S; Dreyling M; Klapper W
    Virchows Arch; 2020 Aug; 477(2):259-267. PubMed ID: 31975037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
    Isaac KM; Portell CA; Williams ME
    Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Right cervical lymph node enlargement].
    Xie JL; Zhou XG; Wang ZQ
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):273-4. PubMed ID: 23928539
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
    Jing C; Zheng Y; Feng Y; Cao X; Xu C
    Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
    Beà S; Amador V
    Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
    Goy A; Kalayoglu Besisik S; Drach J; Ramchandren R; Robertson MJ; Avivi I; Rowe JM; Herbrecht R; Van Hoof A; Zhang L; Cicero S; Fu T; Witzig T
    Br J Haematol; 2015 Aug; 170(4):496-503. PubMed ID: 25921098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma.
    Nygren L; Baumgartner Wennerholm S; Klimkowska M; Christensson B; Kimby E; Sander B
    Blood; 2012 May; 119(18):4215-23. PubMed ID: 22431568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation for mantle cell lymphoma: is it the right thing to do?
    Williams ME
    Hematology Am Soc Hematol Educ Program; 2013; 2013():568-74. PubMed ID: 24319233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX11, a key oncogenic factor in mantle cell lymphoma.
    Beekman R; Amador V; Campo E
    Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma.
    Obr A; Procházka V; Jirkuvová A; Urbánková H; Kriegova E; Schneiderová P; Vatolíková M; Papajík T
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):762-768. PubMed ID: 30146365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
    Silkenstedt E; Linton K; Dreyling M
    Br J Haematol; 2021 Oct; 195(2):162-173. PubMed ID: 33783838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I manage mantle cell lymphoma: indolent versus aggressive disease.
    Wilson MR; Barrett A; Cheah CY; Eyre TA
    Br J Haematol; 2023 Apr; 201(2):185-198. PubMed ID: 36807902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
    Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Molecular Biology and Targeted Therapy of Mantle Cell Lymphoma.
    Klener P
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.